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SUMMARY
Neural tube defects rank second to congenital heart disease as a major cause of
congenital malformation. Recent developments in ultrasound have improved
prenatal diagnosis. Due to anomaly scans at 18 weeks gestation and the avail-
ability ofa genetic clinic, prenatal diagnosis ofneural tube defects at the Royal
Maternity Hospital was 91 2% during 1987-1989. However, only 50% of
parents accept termination of pregnancy and it is questionable if prenatal
diagnosis is ofbenefit to those who wish to continue with thepregnancy. Parents
may accept the situation better at birth, having had time to come to terms with
it, helped with support from the obstetrician, clinical geneticist, paediatrician,
genetic nurse and social worker. For some affected fetuses who have better
muscle function and leg movement at term it appears from the literature that the
outcome may be improved by caesarean section delivery. In Irelandfetuses with
neural tube defects will continue to be delivered, as termination is unacceptable
to many, but despite this there may be a positive benefitfromprenatal diagnosis
of neural tube defects. Prospective randomised controlled trials are needed
to confirm benefit from delivery by caesarean section for fetuses with a good
prognosis. As a result of prenatal diagnosis of a neural tube lesion the fetus
should enjoy benefit in terms of physical morbidity, and the parents should
benefit in terms ofpsychological morbidity.
INTRODUCTION
Neural tube defects are a heterogeneous group of malformations resulting from
failure of neural tube closure up to the fourth week after conception. They have a
multifactorial origin and range widely in severity from anencephaly to surgically
correctable meningocele. They may be accompanied by neurologic, musculo-
skeletal, urologic and developmental abnormalities. They rank second to cardiac
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abnormalities as a cause of major congenital malformation, with a wide variation
in prevalence worldwide and a well recognised increased prevalence in Northern
Ireland of 3-3 per 1000 deliveries. Hydrocephalus is present in 80% of cases
with spina bifida.
Recent ultrasound developments have resulted in better detection of these
conditions prenatally. Anencephaly was the first fetal malformation detected by
ultrasound I and in 1986 Nicolaides described ultrasonic markers of neural tube
defects, scalloping of the frontal bones called 'the lemon sign' and anterior
curvature of the cerebellar hemispheres called 'the banana sign'.2 An alternative
to ultrasound isbiochemical screening bymeasurement ofmaternal serum alpha-
fetoprotein. At present there is no alpha -fetoprotein screening in Ireland and its
use in Great Britain is controversial.
Prenatal diagnosis of a major malformation allows the parents the option of
termination of pregnancy, but it is questionable if it is of any benefit to them if
termination is unacceptable. The aim ofthis paper is to report our experience with
the diagnosis and management of pregnancies complicated by neural tube
defects.
METHODS
Since 1987 in the Royal Maternity Hospital, all women who book early are offered
an ultrasound scan performed at 18 weeks' gestation by ultrasonographers.
A scan carried out at booking allows gestation to be confirmed thus ensuring
accurate timing of this anomaly screening scan. Very few women refuse to have
this anomaly scan booked. Any woman at risk of a child being affected with a
neural tube defect either due toa past obstetricor family history, isoffered referral
to the genetic clinic. Recently maternal alpha -fetoprotein screening has been
introduced for a trial period. These latter procedures are offered as an 'opt-in'
service. If an abnormality is detected by an ultrasonographer at 18 weeks'
gestation, an obstetrician is immediately informed. The obstetrician then informs
the parents ofthe findings and an appointment is made for the next genetic clinic.
At the genetic clinic the parents are seen by a clinical geneticist, prior to a further
ultrasound scan and confirmatory tests performed by an obstetrician trained
in perinatal medicine. Management is individualised after careful discussion
involving the parents, obstetrician and clinical geneticist regarding the severity of
the lesion and prognosis for the child.
If the parents decide that the pregnancy should be terminated, this is performed
using gemeprost pessaries. Should termination be unacceptable, the parents
receivefull support throughout theremainderofthepregnancy. Recently, delivery
by elective caesarean section at 37 weeks' gestation is offered to parents, where it
is felt that there is a good prognosis for the child. Based on postnatal criteria
established by Lorber in 19713 a good functional prognosis is predicted if the
lesion is below the first lumbar vertebra, and is not associated with severe
kyphoscoliosis, severe hydrocephalus or other gross congenital defects.
Pregnancies complicated byneural tubedefects which were managed inthe Royal
Maternity Hospital during the three year period 1987-1989 are reviewed. The
figures were obtained from delivery record books, genetic clinic records and the
Infant Surgical Unit in the Royal Belfast Hospital for Sick Children.
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RESULTS
During the three year period there were 34 pregnancies complicated by neural
tube defects among 10,042 deliveries, a prevalence of 3-4 per 1000 deliveries.
Of the 34 cases, 13 were anencephalics and 18 were spina bifida with or without
hydrocephalus. Three cases wereisolated hydrocephalus. Seventeen werefemale
fetuses, 13 male and four unknown.
Over 90% of the cases were diagnosed prenatally (Table 1). The three undiag-
nosed wereaclosed myelomeningocele, an occipital meningocele andacase with
hydranencephaly. These cases were 'missed' diagnoses rather than 18 week
anomaly scans not done, or refused. Of the three cases diagnosed in the third
trimester one was booked at 33 weeks' gestation. 76-5% of the cases were
diagnosed in the second trimester and an abnormality was missed initially in 14
women who had scans prior to 14 weeks' gestation. 41 % of the abnormalities
were diagnosed at the routine antenatal clinic by ultrasound scan. These were
mostly anencephalic fetuses diagnosed at the booking visit, orfetuses with hydro-
cephalus noted later in the pregnancy. 35%, mainly spina bifida, were identified
at the 18 week scan by the ultrasonographers and 15% were diagnosed at the
genetic clinic in women who were high risk and had accepted genetic counselling.
TABLE I
Prenatal diagnosis ofneural tube defects
Time of diagnosis No ofcases (%)
1st trimester 2 (5-9)
2nd trimester 26 (76-5)
3rd trimester 3 (8-8)
Undiagnosed 3 (8-8)
Sixteen women decided to have the pregnancy terminated after prenatal diag-
nosis. Of 13 women with anencephalic fetuses nine (69%) opted for termination
and of 18 women with spina bifida fetuses seven (39%)opted fortermination. The
severity of the lesion did not always appear to influence the decision, as four
women withanencephalic fetuses continued with thepregnancy (TableII). Marital
status also appeared unimportant, as four of the women were unmarried at the
time of diagnosis; one was late booked, one decided to terminate the pregnancy
and two married after the diagnosis was made and before the delivery.
TABLE II
Action taken afterprenatal diagnosis ofneural tube defect
Action No of cases
Termination of pregnancy 16 (9 anencephaly
7 spina bifida)
Continuation of pregnancy 15 (4 anencephaly
1 1 spina bifida)
Undiagnosed 3
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Two fetuses diagnosed ultrasonically as having encephaloceles had large cystic
hygromas at delivery. Ofthe 18 patients who continued with the pregnancy, eight
had delivery by caesarean section, five electively at 37 weeks' gestation and three
as emergency procedures. Ten women had vaginal delivery, four with associated
destructive procedures. The perinatal outcome is shown in Table 111. All the
babies delivered by caesarean section had five
-minute Apgar scores greater than
seven. The follow up of the nine babies who survived the neonatal period is
shown in Table IV.
TABLE Ill
Perinatal outcome ofpregnancies afterprenatal diagnosis ofneural tube defects
Mode ofdelivery No of cases Outcome
Vaginal delivery with 10 8 stillbirths
or without destructive 1 early neonatal death
procedure 1 livebirth
Caesarean section 8 8 livebirths
TABLE IV
Follow up ofneonates afterprenatal diagnosis ofneural tube defects
Mode of delivery Follow up
Normal vaginal delivery 1 Alive and well
Elective caesarean section 5 4 early closure with or without shunt
Alive and well
1 unsuitable for closure
Alive
Emergency caesarean section 3 2 alive and well
1 died at 15 months
DISCUSSION
The incidence of neural tube defects during 1987 - 1989 in the Royal Maternity
Hospital is similar to the higher than normal prevalence recognised throughout
Northern Ireland. Compared with other studies which report equal distribution
ofanencephaly and spina bifida, we found 52% spina bifida compared with 38%
anencephaly.4 We found a preponderance of abnormality among female fetuses.
Despite achieving a diagnosis in 90% of cases, it was initially missed in fourteen
women who had a scan prior to 14 weeks' gestation, due to difficulty in clear
visualization ofthespine and cerebellum before 18 weeks. No caseofopen neural
tube lesion was missed in those women booked for confinement in the Royal
Maternity Hospital who had a routine ultrasound scan at 18 weeks' gestation
(approximately 10,000 during the three year period).
Regarding prenatal diagnosis, efficacy is described as detection and termination
of those cases within a given population who are known to be affected in utero.
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A discrepancy between diagnosis and efficacy exists due to several factors. Firstly,
women not being screened either because they book late or decline screening,
secondly, inaccuracy of the test itselfand lastly, failure to terminate the pregnancy.
In the present study efficacy was 47 % which is comparable with other studies,5'6
but in studies from England only 10% of women diagnosed as carrying a fetus
with neural tube defects declined termination compared with 50% in our
population.5'6'7 In our clinic the parents are fully supported in whatever decision
they make regarding the pregnancy, and it is therefore difficult to question why
some decide not to have an affected pregnancy terminated, but it is felt that in
most cases it is on religious or conscience grounds.
The recent introduction of gemeprost pessaries has improved the termination
procedure and has almost eliminated the need for extra -amniotic prostaglandin.
It is important that a fetus delivered after an induced abortion for an abnormality
is sent for examiantion by a paediatric pathologist and by a clinical geneticist
experienced in dysmorphology, as this may influence subsequent genetic
counselling.
This point is highlighted in a report from the Manchester Regional Centre where
of 71 cases aborted for neural tube defects, 56 were confirmed, two also had cleft
palates, five had multiple abnormalities, three had autosomal recessive malform-
ations, and one had a cystic hygroma; all of these may lead to an increased risk in
subsequent pregnancies.8 In the majority of our cases although the fetus was
examined by a clinical geneticist, postmortem examination was refused by the
parents. The importance of this procedure should be explained to the parents.
In our study some of the parents of an anencephalic fetus, who had declined
termination, requested early delivery in the third trimester. At this stage these
parents accept 'early delivery' as opposed to 'termination', and we regard this as
supporting the parents in their choice rather than failure of the support system
offered to them. Chervenak et al in 1984 feel that termination at this stage is both
moral and legal if the fetus isaffected with a condition incompatible with postnatal
survival by more than a few weeks, characterised by total or virtual loss of
cognitive function, and where highly reliable diagnostic procedures are available.9
Anencephaly fulfils these criteria, with a study of 102 cases reporting no false
positives or false negatives in prenatal diagnosis.'0 The results of our study were
similar.
Major chromosomal aberrations may be associated with neural tube defects' 1 as
may other anatomical abnormalities and these should be excluded by a detailed
ultrasound scan by an experienced sonographer and by other appropriate invest-
igations e.g. amniocentesis or cordocentesis. The team involved in counselling
should include the obstetrician, clinical geneticist, neonatologist, paediatric
surgeon, genetic nurse and social worker. Where the parents elect to continue
with the pregnancy or when the diagnosis is made late, they should receive full
support throughout the antenatal period.
One advantage of prenatal diagnosis is that it allows choice of timing and mode
of delivery to provide optimal outcome. For those who opt to continue with a
pregnancy after anencephaly has been diagnosed, vaginal delivery should
obviously be aimed for. However, parents should not be told thatthe child will die
immediately, as some survive forshort periods. Aretrospective studyof 130 cases
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with meningomyelocele by Stark and Drummond in 1970,12 reported 14%
showing signs of cerebral birth injury. The authors considered that for many
neonates the neurologic deficit increased during vaginal delivery. There is
evidence from Luthy et al13 that if a fetus with spina bifida has good muscle
function and leg movement by the time the lungs are mature, paralysis is
minimised by an elective caesarean section at 37 weeks' gestation prior to the
onset of labour. This study is the only prospective one; though it was not
randomised. It compares 47 children delivered by elective caesarean section with
113 delivered vaginally or by caesarean section after the onsetof labour. Ofthose
born by pre -labour caesarean section subsequent motor function was better, but
neonatal complications and subsequent intellectual performance showed no
difference between the two groups. The authors claim better outcome was due
partly to a less-impaired series of cases, partly because of selection of only the
least-impaired for caesarean section and less damage to the infants as a result
of the method of delivery. A group from North Carolina reviewed 32 affected
children delivered by caesarean section compared with 40 delivered vaginally
who were followed up for one year. They showed no significant difference in
mortality, hospital stay, neurologic or developmental status.'4
Of the group delivered vaginally, three developed meningitis compared with
only one in the section group but a larger study would be needed to show any
significance inthis finding. Ourfindings, although not randomised orcomparable,
show a poor outcome associated with vaginal delivery, only one of ten surviving.
For the family the quality of life is important. Of the nine survivors in our study
one died at the age of 15 months, one required no treatment after delivery, one
had a lesion too extensive for closure and the remaining six required closure of
the defect. It is impossible to compare the two groups as the cases with better
prognosis were chosen for operative delivery and therefore introduce bias in
favour of better outcome.
What is the future regarding prenatal diagnosis of neural tube defects? It is
generally anticipated that a decreasing number of children will be born with
these conditions as primary prevention and prenatal diagnosis advance further.
However, in Ireland, whether the defect is diagnosed by ultrasound, serum alpha -
fetoprotein or amniocentesis, we will continue to deliver affected babies as
termination is unacceptable to many parents. It is possible that prenatal diagnosis
may not only contribute to decreasing the number of affected children but may
also decrease the associated morbidity and mortality for those who wish to
continue with the pregnancy. Regarding the mode of delivery, each case needs to
be assessed individually. Only a prospective randomised controlled trial involving
agroupof centres will proveany potential benefit from elective caesarean section.
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